Events

Join us for an R&D Update with Mereo BioPharma Group plc (Mereo) featuring pulmonology experts Robert Stockley, MBBS (University Hospital Birmingham, UK) and Robert Sandhaus, MD, PhD (National Jewish Health, US). The call will feature an update on the alvelestat program for alpha-1 antitrypsin deficiency (AATD) and will include presentations from management. A Q&A session will follow the presentations. The post…

Join us for an Analyst & Investor Reception Event at the American Association for the Study of Liver Diseases in Washington D.C. The post ALIGOS Therapeutics: Analyst & Investor Reception at AASLD appeared first on LifeSci Events.

The webinar will feature a presentation from Frank A. Giordano, M.D. (Professor and Chair, Department of Radiation Oncology, University Medical Center Mannheim, Germany), who will present and discuss the latest top-line results of the GLORIA Phase 1/2 trial evaluating NOX-A12 in combination with radiotherapy (RT) ± bevacizumab in patients with newly diagnosed glioblastoma and unmethylated MGMT promoter. The data from…

Join us for a virtual KOL event featuring Jonathan Barratt, PhD, FRCP (University of Leicester) who will discuss the disease burden and pathogenesis of IgA nephropathy (IgAN), as well as atacicept’s clinical data to-date. Atacicept is a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator (BLyS) and a…

Join us virtually for a KOL Event with Gritstone bio, featuring infectious disease expert Professor Andrew Ustianowski, MBBS (North Manchester General Hospital),  immunization expert Shabir Madhi, MBBCh, MMed, FACPaeds, PhD (University of the Witwatersrand and WHO Strategic Advisory Group on Immunization) and Larry Corey, MD, an internationally renowned expert in virology, immunology, vaccine development, and former longtime President of Fred Hutch. Following…

Olema invites you to join us for a virtual webcast and conference call with Sean P. Bohen, M.D., Ph.D., (President & CEO, Olema), Shane Kovacs (COO and CFO, Olema), and Naseem Zojwalla, M.D. (CMO, Olema) to review data presented in a poster at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. The poster title is “Preliminary phase 1/2 results…

Join us for the Sensei Biotherapeutics KOL Event, featuring Robert Schreiber, PhD (Washington University School of Medicine) who will provide background on VISTA (V-domain Immunoglobulin Suppressor of T cell Activation) and discuss the unmet medical needs present in the current immuno-oncology treatment landscape, and the importance of VISTA in developing highly selective therapeutics. The Sensei Biotherapeutics leadership team will provide an overview…

Join us for an R&D Day with Cyclacel Pharmaceuticals, featuring renowned key opinion leaders in oncology and a program update from senior management. Jasmine Zain, MD (City of Hope National Medical Center) will be providing an overview of the unmet medical needs in the treatment of T cell lymphoma. Do-Youn Oh, MD, PhD (Seoul National University) will discuss…

Join us for the Arrowhead Cardiometabolic Virtual Investor & Analyst Event, featuring key opinion leaders, Christie Ballantyne, M.D., (Baylor College of Medicine) and Robert Rosenson, M.D. (Icahn School of Medicine at Mount Sinai), who will discuss the Phase 2 data presented on the Company’s investigational cardiometabolic candidates, ARO-APOC3 and ARO-ANG3, in late-breaking oral presentations at AHA, as well as the…